Transportation & Logistics » Air Transport | BioCube Inc.

BioCube Inc. | Income Statement

Fiscal year is February-January. All values USD Thousands.
2010
2011
2012
2013
2016
Cost of Goods Sold (COGS) incl. D&A
-
1.50
103.00
-
-
Gross Income
-
1.50
103.00
-
-
SG&A Expense
94.10
257.60
178.40
379.20
290.50
EBIT
94.10
259.10
281.40
379.20
365.00
Unusual Expense
-
413.20
320.50
29.20
-
Interest Expense
29.90
359.70
130.70
356.10
169.80
Pretax Income
124.00
1,032.00
91.60
764.50
534.80
Consolidated Net Income
124.00
1,032.00
91.60
764.50
534.80
Net Income
124.00
1,032.00
91.60
764.50
534.80
Net Income After Extraordinaries
124.00
1,032.00
91.60
764.50
534.80
Net Income Available to Common
124.00
1,032.00
91.60
764.50
534.80
EPS (Basic)
0.01
0.04
-
0.02
0.01
Basic Shares Outstanding
19,977.80
24,868.20
28,727.80
30,901.70
54,112.50
EPS (Diluted)
0.01
0.04
0.00
0.02
0.01
Diluted Shares Outstanding
19,977.80
24,868.20
28,727.80
30,901.70
54,112.50
EBITDA
-
257.60
178.40
379.20
365.00
Other Operating Expense
-
-
-
-
74.50

About BioCube

View Profile
Address
7320 North Dreamy Draw Drive
Phoenix Arizona 85020
United States
Employees -
Website -
Updated 07/08/2019
BioCube, Inc. operates as a biotechnology company which engages in identifying and facilitating the development of technologies, products, and services for medical and biological applications. Its products include cannasens delta9, american cannabis, and canadian cannabis. The company was founded on April 20, 2009 and is headquartered in Phoenix, AZ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.